BamSEC and AlphaSense Join Forces
Learn More

Damora Therapeutics Inc. – Indentures

NASDAQ: DMRA    
Share price (8/17/26): $31.09    
Market cap (8/17/26): $1.919 billion
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.7
from S-8 POS 33 pages Damora Therapeutics, Inc. 2020 Equity Incentive Plan
12/34/56
EX-4.7
from S-8 POS 33 pages Damora Therapeutics, Inc. 2020 Equity Incentive Plan
12/34/56
EX-4.7
from S-8 POS 33 pages Damora Therapeutics, Inc. 2020 Equity Incentive Plan
12/34/56
EX-4.7
from S-8 POS 33 pages Damora Therapeutics, Inc. 2020 Equity Incentive Plan
12/34/56
EX-4.7
from S-8 POS 33 pages Damora Therapeutics, Inc. 2020 Equity Incentive Plan
12/34/56
EX-4.7
from S-8 POS 33 pages Damora Therapeutics, Inc. 2020 Equity Incentive Plan
12/34/56
EX-4.7
from S-8 POS 33 pages Damora Therapeutics, Inc. 2020 Equity Incentive Plan
12/34/56
EX-4.7
from S-8 POS 33 pages Damora Therapeutics, Inc. 2020 Equity Incentive Plan
12/34/56
EX-4.6
from S-8 POS 16 pages Damora Therapeutics, Inc. 2020 Stock Option and Grant Plan
12/34/56
EX-4.6
from S-8 POS 16 pages Damora Therapeutics, Inc. 2020 Stock Option and Grant Plan
12/34/56
EX-4.6
from S-8 POS 16 pages Damora Therapeutics, Inc. 2020 Stock Option and Grant Plan
12/34/56
EX-4.6
from S-8 POS 16 pages Damora Therapeutics, Inc. 2020 Stock Option and Grant Plan
12/34/56
EX-4.6
from S-8 POS 16 pages Damora Therapeutics, Inc. 2020 Stock Option and Grant Plan
12/34/56
EX-4.6
from S-8 POS 16 pages Damora Therapeutics, Inc. 2020 Stock Option and Grant Plan
12/34/56
EX-4.6
from S-8 POS 16 pages Damora Therapeutics, Inc. 2020 Stock Option and Grant Plan
12/34/56
EX-4.6
from S-8 POS 16 pages Damora Therapeutics, Inc. 2020 Stock Option and Grant Plan
12/34/56
EX-4.5
from S-8 POS 15 pages Damora Therapeutics, Inc. 2022 Inducement Plan
12/34/56
EX-4.5
from S-8 POS 15 pages Damora Therapeutics, Inc. 2022 Inducement Plan
12/34/56
EX-4.5
from S-8 POS 15 pages Damora Therapeutics, Inc. 2022 Inducement Plan
12/34/56
EX-4.5
from S-8 POS 15 pages Damora Therapeutics, Inc. 2022 Inducement Plan
12/34/56